文献速递神经肿瘤神经重症

伽玛刀放射外科治疗大型后颅窝转移瘤及其瘤周水肿相关占位效应的效果

The effect of Gamma Knife radiosurgery on large posterior fossa metastases and the associated mass effect from peritumoral edema.
PubMed 文献 · J Neurosurg · 2020-01-24

单中心回顾性分析49例患者51个大型(≥2 cm)后颅窝脑转移瘤,评估伽玛刀单药治疗对肿瘤、瘤周水肿及第四脑室体积的影响。首次随访(治疗后2个月)肿瘤体积中位缩小58.66%、瘤周水肿中位缩小78.10%、第四脑室中位扩大24.97%(均p<0.001),局部控制率98.1%,中位总生存8.36个月。作者认为伽玛刀耐受良好,可考虑用于特定病例,尤其是手术条件差的患者。

要点

  • 首次随访肿瘤体积中位缩小58.66%、瘤周水肿中位缩小78.10%、第四脑室中位扩大24.97%(均p<0.001)。
  • 首次随访局部控制率98.1%,中位总生存8.36个月。
  • 治疗至首次随访间无患者需手术、外引流或分流,1例在治疗后23个月行脑室腹腔分流。

核心结论

  • 回顾性分析显示,伽玛刀治疗大型后颅窝转移瘤后肿瘤体积和瘤周水肿显著缩小、第四脑室明显开放(均p<0.001)。
  • 作者认为伽玛刀耐受良好,可考虑用于特定大型后颅窝转移瘤病例,尤其是手术条件差的患者。

研究设计与样本

  • 单中心回顾性综述,纳入49例连续患者共51个大型(≥2 cm)后颅窝脑转移瘤,均接受伽玛刀放射外科单药治疗。
  • 纳入标准为至少完成1次临床和影像学随访;采用肿瘤、瘤周水肿和第四脑室体积测量评估疗效与安全性,总生存为次要结局。

主要发现

  • 患者57.1%为男性,伽玛刀时中位年龄61.5岁,中位卡氏功能状态评分90。
  • 中位大型后颅窝转移瘤数目为1个、整体脑转移瘤数目为2个;诊断时中位肿瘤体积4.96 cm3(范围1.4-21.1 cm3)、瘤周水肿体积14.98 cm3(范围0.6-71.8 cm3)、第四脑室体积1.23 cm3(范围0.3-3.2 cm3),中位病灶直径2.6 cm(范围2.0-5.07 cm)。
  • 中位随访时间7.3个月(范围1.6-57.2个月);治疗后2个月首次随访时肿瘤体积中位缩小58.66%(范围-96.95%至+48.69%,p<0.001),瘤周水肿中位缩小78.10%(范围-99.92%至+198.35%,p<0.001),第四脑室中位扩大24.97%(范围-37.96%至+545.6%,p<0.001)。
  • 首次随访局部控制率98.1%,中位总生存8.36个月。
  • 治疗至首次随访间无患者需手术干预、外心室引流或分流;1例在治疗后23个月需脑室腹腔分流;治疗后65.30%接受本院常规激素减量方案,6.12%未用激素,28.58%需延长激素治疗。

关键数值与推荐

  • 大型后颅窝脑转移瘤定义为直径≥2 cm。
  • 疗效评估采用肿瘤、瘤周水肿和第四脑室体积测量;首次随访为治疗后2个月。
  • 局部控制率98.1%,中位总生存8.36个月。

临床怎么用

  • 作者认为伽玛刀耐受良好,可考虑用于特定大型后颅窝转移瘤病例,尤其是手术条件差的患者。
  • 本研究中心的做法是治疗后采用常规激素减量方案(65.30%患者接受)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Gamma Knife radiosurgery (GKRS) as monotherapy is an option for the treatment of large (≥ 2 cm) posterior fossa brain metastases (LPFMs). However, there is concern regarding possible posttreatment increase in peritumoral edema (PTE) and associated compression of the fourth ventricle. This study evaluated the effects and safety of GKRS on tumor and PTE control in LPFM. METHODS: The authors performed a single-center retrospective review of 49 patients with 51 LPFMs treated with GKRS. Patients with at least 1 clinical and radiological follow-up visit were included. Tumor, PTE, and fourth ventricle volumetric measurements were used to assess efficacy and safety. Overall survival was a secondary outcome. RESULTS: Fifty-one lesions in 49 consecutive patients were identified; 57.1% of patients were male. At the time of GKRS, the median age was 61.5 years, and the median Karnofsky Performance Status score was 90. The median number of LPFMs and overall brain metastases were 1 and 2, respectively. The median overall tumor, PTE, and fourth ventricle volumes at diagnosis were 4.96 cm3 (range 1.4-21.1 cm3), 14.98 cm3 (range 0.6-71.8 cm3), and 1.23 cm3 (range 0.3-3.2 cm3), respectively, and the median lesion diameter was 2.6 cm (range 2.0-5.07 cm). The median follow-up time was 7.3 months (range 1.6-57.2 months). At the first follow-up, 2 months posttreatment, the median tumor volume decreased by 58.66% (range -96.95% to +48.69%, p < 0.001), median PTE decreased by 78.10% (range -99.92% to +198.35%, p < 0.001), and the fourth ventricle increased by 24.97% (range -37.96% to +545.6%, p < 0.001). The local control rate at first follow-up was 98.1%. The median OS was 8.36 months. No patient required surgical intervention, external ventricular drainage, or shunting between treatment and first follow-up. However, 1 patient required a ventriculoperitoneal shunt at 23 months from treatment. Posttreatment, 65.30% received our general steroid taper, 6.12% received no steroids, and 28.58% required prolonged steroid treatment. CONCLUSIONS: In this retrospective analysis, patients with LPFMs treated with GKRS had a statistically significant posttreatment reduction in tumor size and PTE and marked opening of the fourth ventricle (all p < 0.001). This study demonstrates that GKRS is well tolerated and can be considered in the management of select cases of LPFMs, especially in patients who are poor surgical candidates.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Muhsen BA, Joshi KC, Lee BS, et al. The effect of Gamma Knife radiosurgery on large posterior fossa metastases and the associated mass effect from peritumoral edema. J Neurosurg. 2020. PMID: 31978879. doi:10.3171/2019.11.JNS191485

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。